Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

  • Reza Bayat Mokhtari1, 2, 3, 6Email author,
  • Narges Baluch5,
  • Micky Ka Hon Tsui1,
  • Sushil Kumar1,
  • Tina S. Homayouni1,
  • Karen Aitken1,
  • Bikul Das6,
  • Sylvain Baruchel4 and
  • Herman Yeger1, 2, 3Email author
BMC Cancer201717:156

https://doi.org/10.1186/s12885-017-3126-7

Received: 15 October 2016

Accepted: 8 February 2017

Published: 24 February 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Oct 2016 Submitted Original manuscript
3 Nov 2016 Reviewed Reviewer Report - Ruchi Saxena
7 Nov 2016 Reviewed Reviewer Report - Vikas Mishra
5 Jan 2017 Author responded Author comments - Reza Bayat Mokhtari
Resubmission - Version 2
5 Jan 2017 Submitted Manuscript version 2
17 Jan 2017 Author responded Author comments - Reza Bayat Mokhtari
Resubmission - Version 3
17 Jan 2017 Submitted Manuscript version 3
3 Feb 2017 Author responded Author comments - Reza Bayat Mokhtari
Resubmission - Version 4
3 Feb 2017 Submitted Manuscript version 4
Publishing
8 Feb 2017 Editorially accepted
24 Feb 2017 Article published 10.1186/s12885-017-3126-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Developmental and Stem Cell Biology, The Hospital for Sick Children
(2)
Department of Paediatric Laboratory Medicine, The Hospital for Sick Children
(3)
Institute of Medical Science, University of Toronto
(4)
Department of Paediatrics, Division of Hematology/Oncology, The Hospital for Sick Children
(5)
Department of Pathology and Molecular Medicine, Queen’s University
(6)
Department of Immunology and Infectious Diseases, The Forsyth Institute

Advertisement